Pfizer appoints Annaliesa Anderson as Senior Vice President
New York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Jansen, Ph.D., who will be retiring from Pfizer.
With more than two decades of biopharmaceutical R&D experience, Dr. Anderson most recently served as Vice President and Chief Scientific Officer for Bacterial Research and Hospital within the Vaccine R&D organization. Under her leadership, Pfizer advanced into clinical development or approval bacterial vaccine programs directed at the prevention of diseases due to Streptococcus pneumoniae, Group B Streptococcus, Neisseria meningitidis, Staphylococcus aureus, and Clostridium difficile. Over the last two years, Dr. Anderson has led the team of infectious disease biologists that validated and delivered to an emergency use authorization PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), Pfizer's novel COVID-19 oral treatment.
"Annaliesa is a world-class scientist with a track record of delivering both vaccines and therapeutics in pioneering new areas of science and where there is urgent unmet need. I am confident she will work with passion, ingenuity, and dedication to lead Pfizer's Vaccine R&D organization and continue to advance our strong pipeline," said Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer. "I want to thank Kathrin for her tremendous contribution to our scientific community and the world at large. She leaves Pfizer's Vaccine R&D group stronger than ever and poised to continue to deliver innovative science."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.